Publications by authors named "Martin Reinsch"

Claim this Profile
B
Bioequivalence and Pharmacokinetics of Low-Dose Anagrelide 0.5 mg Capsules in Healthy Volunteers.
Ahmet Inal, Zafer Sezer, Onur Pinarbasli, Burcu Bulut, Martin Reinsch

Biomedicines· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence study of two formulations of lurasidone film coated tablets in healthy subjects under fed conditions.
Gökçe Sözer, Muradiye Nacak, Erol Durucu, Wolfgang Martin, Martin Reinsch

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects.
Ahmet Inal, Zafer Sezer, Onur Pinarbasli, Burcu Bulut, Martin Reinsch

BMC Pharmacol Toxicol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence study of low dose drospirenone/ethinyl estradiol 3 mg/0.03 mg film tablets under fasting conditions in Turkish healthy female subjects.
Ahmet Inal, Zafer Sezer, Berna Uluözlü, Melih Oflas, Martin Reinsch

Pharmacol Res Perspect· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence Study of Capsules versus Film Tablets Containing Rivaroxaban in Healthy Caucasian Subjects under Fasting and Fed Conditions.
Gökçe Sözer, Ahmet Inal, Zafer Sezer, Wolfgang Martin, Ewald Ottmann, Martin Reinsch

Clin Pharmacol Drug Dev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic and Cerebral Concentration of Nimodipine During Established and Experimental Vasospasm Treatment.
Walid Albanna, Miriam Weiss, Catharina Conzen, Hans Clusmann, Toni Schneider, Martin Reinsch

World Neurosurg· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses.
Bernd Fink, Sebastian Vogt, Martin Reinsch, Hubert Büchner

Clin Orthop Relat Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis